Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IB”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT02975141
What this trial is testing

Afatinib and Gemcitabine/Nab-paclitaxel in Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
PD Dr. med. Volker Heinemann 12
Early research (Phase 1)Study completedNCT03207529
What this trial is testing

Alpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast Cancer

Who this might be right for
Advanced Breast CarcinomaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+15 more
M.D. Anderson Cancer Center 18
Early research (Phase 1)UnknownNCT05185531
What this trial is testing

Neoadjuvant Tislelizumab With SBRT in Patients With Resectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shandong Cancer Hospital and Institute 20
Testing effectiveness (Phase 2)Ended earlyNCT02392377
What this trial is testing

Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination Chemotherapy

Who this might be right for
Stage IB Esophageal AdenocarcinomaStage IIA Esophageal AdenocarcinomaStage IIB Esophageal Adenocarcinoma+3 more
Case Comprehensive Cancer Center 1
Early research (Phase 1)Study completedNCT01469572
What this trial is testing

Pasireotide, Everolimus and Selective Internal Radioembolization Therapy for Unresectable Hepatic Metastases

Who this might be right for
Neuroendocrine Tumors
Emory University 13
Early research (Phase 1)Study completedNCT02650713
What this trial is testing

The Safety, Pharmacokinetics, and Therapeutic Activity of RO6958688 in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen (CEA)-Positive Solid Tumors

Who this might be right for
Solid Tumors
Hoffmann-La Roche 228
Early research (Phase 1)Study completedNCT01613950
What this trial is testing

PI3K Inhibitor BYL719 in Combination With the HSP90 Inhibitor AUY922 in Patients With Advanced or Metastatic Gastric Cancer

Who this might be right for
Stomach Neoplasms Esophageal Neoplasms Metastatic Gastric Cancer Mutated PI3KCA Protein Overexpressed HER2 Protein
Novartis Pharmaceuticals 18
Testing effectiveness (Phase 2)Study completedNCT02600897
What this trial is testing

Obinutuzumab, Polatuzumab Vedotin, and Lenalidomide in Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab in Combination With Polatuzumab Vedotin and Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Relapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Hoffmann-La Roche 114
Early research (Phase 1)Not Yet RecruitingNCT07283640
What this trial is testing

A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia

Who this might be right for
BlinatumomabRevumenibLymphoblastic Leukemia+1 more
M.D. Anderson Cancer Center 20
Early research (Phase 1)UnknownNCT04134000
What this trial is testing

Atezolizumab and BCG in High Risk BCG naïve Non-muscle Invasive Bladder Cancer (NMIBC) Patients (BladderGATE)

Who this might be right for
Invasive Bladder Cancer
Fundacion Oncosur 40
Testing effectiveness (Phase 2)Study completedNCT01106898
What this trial is testing

Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Stage I-II Breast Cancer Who Have Undergone Surgery

Who this might be right for
Stage IA Breast CancerStage IB Breast CancerStage IIA Breast Cancer+1 more
University of Nebraska 112
Testing effectiveness (Phase 2)UnknownNCT04376931
What this trial is testing

A Prospective Dose Finding Study of Iscador Infusion

Who this might be right for
Advanced Cancer
HaEmek Medical Center, Israel 24
Not applicableWithdrawnNCT05093712
What this trial is testing

Patient-Informed Educational Intervention for the Improvement of Cervical Cancer Literacy

Who this might be right for
Stage IB Cervical Cancer FIGO 2018Stage IB1 Cervical Cancer FIGO 2018Stage IB2 Cervical Cancer FIGO 2018+13 more
M.D. Anderson Cancer Center
Early research (Phase 1)Ended earlyNCT01496534
What this trial is testing

Phase Ib Study of Gemcitabine Plus Cisplatin or Carboplatin Plus Dovitinib in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorsBladder Cancer
Matthew Galsky 14
Early research (Phase 1)Study completedNCT02343172
What this trial is testing

Study of Safety and Efficacy of HDM201 in Combination With LEE011 in Patients With Liposarcoma

Who this might be right for
Liposarcoma
Novartis Pharmaceuticals 74
Testing effectiveness (Phase 2)WithdrawnNCT03697239
What this trial is testing

High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic CancerPancreatic CancerPancreas Cancer+3 more
Hitendra Patel
Testing effectiveness (Phase 2)UnknownNCT05102292
What this trial is testing

The Efficacy and Safety of HLX208 in Advanced Anaplastic Thyroid Cancer (ATC) With BRAF V600 Mutation

Who this might be right for
Anaplastic Thyroid CancerATC
Shanghai Henlius Biotech 25
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Study completedNCT02024607
What this trial is testing

BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Advanced Gastrointestinal Cancer
Sumitomo Pharma America, Inc. 495
Early research (Phase 1)Ended earlyNCT04810611
What this trial is testing

Phase Ib Study of Select Drug Combinations in Patients With Lower Risk MDS

Who this might be right for
Myelodysplastic Syndromes
Novartis Pharmaceuticals 33
Next Page